Literature DB >> 3230268

Current trends in the endocrine use of ketoconazole.

N Sonino1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3230268     DOI： 10.1007/BF03350938

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  10 in total

1.  Use of ketoconazole in the treatment of Cushing's syndrome.

Authors:  P Loli; M E Berselli; M Tagliaferri
Journal:  J Clin Endocrinol Metab       Date:  1986-12       Impact factor: 5.958

2.  Ketoconazole inhibits corticotropic cell function in vitro.

Authors:  G K Stalla; J Stalla; M Huber; J P Loeffler; V Höllt; K von Werder; O A Müller
Journal:  Endocrinology       Date:  1988-02       Impact factor: 4.736

Review 3.  The use of ketoconazole as an inhibitor of steroid production.

Authors:  N Sonino
Journal:  N Engl J Med       Date:  1987-09-24       Impact factor: 91.245

4.  Hormonal and clinical effects of ketoconazole in hirsute women.

Authors:  H Martikainen; J Heikkinen; A Ruokonen; A Kauppila
Journal:  J Clin Endocrinol Metab       Date:  1988-05       Impact factor: 5.958

5.  Ketoconazole as a possible universal inhibitor of cytochrome P-450 dependent enzymes: its mode of inhibition.

Authors:  Y Higashi; M Omura; K Suzuki; H Inano; H Oshima
Journal:  Endocrinol Jpn       Date:  1987-02

6.  Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells.

Authors:  S W Lamberts; E G Bons; H A Bruining; F H de Jong
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

7.  In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis.

Authors:  H Van den Bossche; G Willemsens; W Cools; F Cornelissen; W F Lauwers; J M van Cutsem
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

8.  Response of pituitary-adrenal axis to corticotrophin releasing hormone in patients with Cushing's disease before and after ketoconazole treatment.

Authors:  M Boscaro; N Sonino; A Rampazzo; F Mantero
Journal:  Clin Endocrinol (Oxf)       Date:  1987-10       Impact factor: 3.478

9.  Clinical experience with ketoconazole as a therapy for patients with Cushing's syndrome.

Authors:  D R McCance; D R Hadden; L Kennedy; B Sheridan; A B Atkinson
Journal:  Clin Endocrinol (Oxf)       Date:  1987-11       Impact factor: 3.478

10.  Long-term experience with high dose ketoconazole therapy in patients with stage D2 prostatic carcinoma.

Authors:  A Pont
Journal:  J Urol       Date:  1987-05       Impact factor: 7.450
  10 in total
  2 in total

1.  Diagnosis and treatment of Cushing's syndrome. Cushing's syndrome: current clinical problems, symposium. Padova, October 19-20, 1990.

Authors: 
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

2.  Cushing's syndrome in medullary thyroid carcinoma.

Authors:  A Mure; C Gicquel; N Abdelmoumene; F Tenenbaum; C Francese; J P Travagli; P Gardet; M Schlumberger
Journal:  J Endocrinol Invest       Date:  1995-03       Impact factor: 4.256
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.